|
|
SPOT ON
|
|
Pharmaceutical industry-funded research - potential for manipulation
|
|
|
NEW ON THE MARKET
|
|
Nothing new - indacaterol (ONBREZ) for COPD
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Doubts over data on oseltamivir (TAMIFLU)
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Coenzyme Q10: during statin treatment required?
|
|
Dramatic rise in prices of influenza vaccines
|
|
|
IN BRIEF
|
|
Ginkgo biloba (TEBONIN, generics) without effect on cognitive decline
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Allergic vasculitis due to tolperisone (e.g. MYDOCALM)
|
|
|
SIDE EFFECTS
|
|
Chitosan (e.g. FORMOLINE L112) interactions
Breast cancer due to finasteride (PROSCAR, generics)
|
|
|
e a-t IN THE INTERNET
|
|
Baclofen (LIORESAL) in alcohol dependence?
|
|